By engaging all three pathways simultaneously, retatrutide is designed to produce a more pronounced and sustained effect on body weight, blood glucose regulation, and metabolic function than single or dual agonists
10.1146/annurev.pharmtox.47.120505.105122 Annu
Description KLOW is a four-component lyophilized research blend combining four peptides studied in tissue repair, dermal biology, and inflammation research literature: BPC-157 (Body Protection Compound-157, a synthetic 15-amino-acid gastric peptide), TB-500 / Thymosin Beta-4 (a 43-amino-acid -thymosin family peptide), GHK-Cu (Copper Tripeptide-1, the glycyl-L-histidyl-L-lysine copper complex), and KPV (Lys-Pro-Val, an -MSH-derived anti-inflammatory tripeptide)
Since 2023, there has been a worldwide shortage of GLP-1 receptor agonists, which is expected to continue until late 2024 [71]
Learn about Ozempic benefits and side effects
At starting doses of 0.5 to 2 mg, the injection volumes are small